<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26573480</identifier>
<setSpec>0034-7450</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Corredor, Catalina Ayala</dc:author>
<dc:author>Castillo, Carolina Solís</dc:author>
<dc:description xml:lang="en">INTRODUCTION In liaison psychiatry it is possible to get an integral view of patient's treatment and needs, paying special attention to pharmacological interactions and contraindications. Some particular cases motivated the description, report and review about other possible applications of 5HT2A and 5HT3 antagonist, particularly Mirtazapine and Olanzapine, in hyperalgesia syndrome, tinnitus and Progressive Multifocal Leukoencephalopathy by JC virus. METHOD Cases report. RESULTS We describe 3 cases of patients in which Mirtazapine and Olanzapine were necessary not only to control psychiatric symptoms (affective / behavioral symptoms and insomnia) but to act as adjuvant therapy in axis III diseases. The use of any drug in psychiatry must take in to account the context of the patient, the presence of comorbidity, contraindications and pharmacological interactions so as to grant a positive outcome also promoting the multidisciplinary work between specialists.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>olanzapine</dc:subject>
<dc:subject>Mirtazapina</dc:subject>
<dc:subject>encefalopatía</dc:subject>
<dc:subject>hiperalgesia</dc:subject>
<dc:subject>tinnitus</dc:subject>
<dc:subject>Mirtazapine</dc:subject>
<dc:subject>hyperalgesia</dc:subject>
<dc:subject>encephalopathy</dc:subject>
<dc:subject>olanzapina</dc:subject>
<dc:subject>tinitus</dc:subject>
<dc:date>2012 Mar </dc:date>
<dc:title xml:lang="es">Otras posibles aplicaciones clínicas de fármacos con efecto 5HT2A y 3 en psiquiatría de enlace: reporte de casos.</dc:title>
<dc:title xml:lang="en">[Other Possible Clinical Applications of Drugs with 5HT2A effect in Liaison Psychiatry: Cases Report].</dc:title>
<dc:publisher>Revista colombiana de psiquiatria</dc:publisher>
</metadata>
</record>
</pubmed-document>
